Company news
Biotalys Nv (EURONEXT:BTLS) news
Biotalys Nv news releases on 6ix. Latest, Sep 28, 2026: Industry Leaders Christine Berwaerts and Ioana Tudor Join Biotalys’ Board as Independent Directors
Press releases & updates
Industry Leaders Christine Berwaerts and Ioana Tudor Join Biotalys’ Board as Independent Directors
September 28, 2026
Biotalys Secures Product Registration in California for EVOCA®, Strengthening Regulatory Pathway for Its Lead Asset EVOCA NG
September 2, 2026
Biotalys Reports Half-Year 2026 Financial Results & Business Highlights
August 20, 2026
Biotalys Notice of Publication Half Year 2026 Financial Results and Business Highlights
July 6, 2026
Biotalys Advances towards Registration of EVOCA in California with Start of Public Consultation
July 1, 2026
Biotalys Announces Retirement of Board Member Patrick Van Beneden
June 30, 2026
Publication of transparency notifications
May 28, 2026
Biotalys Announces Closing of Private Placement
May 20, 2026
Biotalys Obtains Subscription Commitments for EUR 12.05 Million through a Private Placement of New Shares with Current Investors
May 6, 2026
Biotalys Reports Full-Year 2025 Financial Results and Business Highlights
April 29, 2026
Biotalys Achieves First U.S. State Registration for EVOCA in Florida
April 27, 2026
Biotalys Achieves First Milestone in Bioinsecticide Partnership with Syngenta
April 7, 2026
Biotalys Announces New Dates for the Publication of its 2025 Annual Report and for its Annual Shareholders Meeting
March 24, 2026
Biotalys Announces Changes to its Board of Directors and Executive Committee
March 17, 2026
Biotalys Notice of Publication 2025 Annual Report and Financial Results
February 24, 2026
Biotalys Announces Intention to Strategically Refocus its Activities to Prioritize Lead Assets and Reduce Annual Cash Burn
February 9, 2026
Biotalys and 21st.BIO Enter into Strategic Partnership to Advance Biocontrol Production
January 23, 2026
Biotalys Receives Regulatory Approval by U.S. EPA for EVOCA
December 2, 2025
EPA Issues Proposed Registration Decision for Biotalys’ EVOCA™ Biofungicide
October 31, 2025
Regulated information
October 20, 2025
Biotalys Reports Half-Year 2025 Financial Results and Business Highlights
September 18, 2025
Biotalys Provides Regulatory Review Update for EVOCA in the U.S.
August 29, 2025
Information on the total number of voting rights and shares
July 30, 2025
Publication of transparency notification
June 16, 2025
Biotalys Reports Progress in the Regulatory Review of EVOCA in both US and EU
June 11, 2025
Biotalys Appoints Luc Van fraeyenhoven as Chief Financial Officer
May 26, 2025
Biotalys and AgroFresh Partner to Protect Fresh Produce
May 20, 2025
Results of the Ordinary Shareholders’ Meeting
April 22, 2025